Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

OBJECTIVE: This paper prospectively evaluates the long-term follow-up [mean ± standard deviation (SD) duration: 89.7±19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab. MATERIALS AND METHODS: Rituximab was admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Hindilerden, Fehmi, Yönal-Hindilerden, İpek, Yenerel, Mustafa Nuri, Nalçacı, Meliha, Diz-Küçükkaya, Reyhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451692/
https://www.ncbi.nlm.nih.gov/pubmed/27102929
http://dx.doi.org/10.4274/tjh.2016.0086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451692/
https://www.ncbi.nlm.nih.gov/pubmed/27102929
http://dx.doi.org/10.4274/tjh.2016.0086

Ejemplares similares